Expert insights. Personalized for you.
for the production R&D of pharmaceutical grade standardised cannabis. Here the company shares their evolution with Health Europa, exploring the production of pharmaceutical grade standardised cannabis. KANNABEIRA® is a project and a registered trademark under the company Green Donation, Ltd. KANNABEIRA and standardised cannabis. MORE
Under the terms of the Agreement, ICC will supply NUBU will a suite of full-spectrum pharmaceutical grade medical cannabis products including: Packaged and labelled medical cannabis including; oil/tincture and capsules in finished goods form. ICC International Cannabis Corp. CSE: WRLD.U)(FWB: MORE
TSXV: LG and OTC-QB: LGGCF) (“ LGC ”) is pleased to announce that it has paid the 2 nd Tranche, as contractually agreed, in acquiring an equity interest in the Italian pharmaceutical company, Freia Farmaceutici Srl (“Freia”). This EU pharmaceutical entity is an optimal addition to LGC. MORE
Press Release: Thailand Government Pharmaceutical Organization. And nervous pain Add research to various types of Parkinson’s Alzheimer’s patients. Dr. Sophon Mektana, Advisor to the Minister of Public Health And the Chairman of the Pharmaceutical Organization Committee. MORE
Some patients find success with pharmaceuticals and talk-therapy. In addition to these medical interventions, Medical marijuana may also be beneficial to clinically depressed patients. Medical marijuana is another option for patients suffering from anxiety. Patient self-reporting and clinical trials are the most efficient methods of understanding how well medical cannabis can help even those with severe symptoms related to depression. MORE
Cannabis possesses healing properties which can aid in a patient’s overall healthcare routine. In particular, terpenoids are contained in many herbal plants, and several terpenoids have been shown to be available for pharmaceutical applications. The trained staff at the Medical Marijuana Treatment Center will assist each patient in selecting the appropriate cannabis products. cannabis cannabis research Health marijuana strains Patient Education Terpenes MORE
SB1719 allows “registered agents” for those patients physically unable to pick up or receive delivery of their medical cannabis, like those in hospice, assisted living facilities, and those who rely on home healthcare providers. Virginia SB1719 passes the House of Delegates. MORE
Dissolve Strips ™ (sublingual cannabis wafers) Now Available to Aurora’s Canadian Medical Patients NYSE | TSX: ACB OTC: CTTH EDMONTON and HAMILTON, ON, Oct. MORE
Cannabis possesses healing properties which can aid in a patient’s overall healthcare routine. In particular, terpenoids are contained in many herbal plants, and several terpenoids have been shown to be available for pharmaceutical applications. When terpenes and cannabinoids interact together, there is a heightened efficacy for medical marijuana patients. cannabis cannabis research education Health marijuana marijuana strains Patient Education Terpenes MORE
In May 2014, Barnaby Joyce spoke out in support of legalising cannabis medicine: a campaign fronted by a young patient named Dan Haslam. “We speculate that the tight regulation is more a means of control and restriction with the aim of keeping Australian patient numbers minimal.” MORE
An Introductory Lesson on THC Basics For Medical Cannabis Patients. Cannabis, a plant that has proven to be endlessly complex is still under the microscope by researchers, patients, physicians, and society. MORE
No need to take pills that could do more harm than good; or deal with painful side effects that pharmaceuticals cause. Patients that are seeking a natural and alternative medicine to the condition they are facing can register for a medical marijuana card by starting here. Furthermore, depending on the state of residency, a medical marijuana card also permits patients to cultivate their own medicine. Patient intake form. Patient Education MORE
So even when patients use CBD oil with essentially no THC, doctors need to understand a lot more about the complex chemical reactions of cannabinoids and terpenes. As farmers widely grow hemp for a variety of purposes, the pharmaceutical industry is not able to control the supply of CBD oil. MORE
One of the obstacles that a hospice patient who chooses medicinal cannabis faces is financial burden. Currently, most hospice patients are covered through Medicare and, unfortunately, that doesn’t include this alternative treatment. Written by Erin Bilenki, Patient Consultant. MORE
We are proud of the positive impact this medicine has already had on thousands of patients and believe that this past year provides a compelling foundation for continued success in 2020,” said Justin Gover, GW’s Chief Executive Officer. Enquiries: GW Pharmaceuticals plc. MORE
Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. One patient died but it was ruled to be part of the course of their disorder and not a drug effect. MORE
Since then, countless patients found relief in cannabis, even though most of the times doctors would only recommend it when all other “mainstream” options were exhausted. However, some people don’t react well to antiemetics—most notably cancer patients going through aggressive chemo. MORE
As the rate of cancer diagnoses rises worldwide, patients are finding more options with their treatments and healthcare routines. Patients can suffer from the disease itself, or from the side effects of chemotherapy and other pharmaceuticals medications. Patients report experiencing anxiety, insomnia, appetite issues, nausea, vomiting and fatigue. This epidemic affects not only patients, but their families and caregivers. MORE
On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. MORE
to bring the CannatolRx Rescue Nasal Spray to Illinois patients,” said Nature’s Grace and Wellness COO Tim O’Hern. This product is a natural extension of our patient-focused mission and a product that has been missing from Illinois for far too long.”. MEDICAL CANNABIS PHARMACEUTICALS MORE
Patients often report feeling relief almost immediately. This strain is known to increase energy and a creative flow in patients; some report even feeling more focused and productive. This is not the strain for patients who suffer from insomnia which is why most patients find this strain to be most effective for daytime use. Many patients living with PTSD, anxiety and depression may find that OG Kush sufficiently helps their symptoms. MORE
THC, and cannabinoid pharmaceuticals have been studied for several medical applications, including the treatment of nausea, pain, anorexia and weight loss, neurodegeneration and neuropathy. The post How medical cannabis can aid cancer patients appeared first on 420Clinic. MORE
Portugal this week rejected the idea of legalising recreational cannabis, although medicinal marijuana is now available for patients in the country. If you wish to re-publish this story please do so with following accreditation. AUTHOR: Mark Taylor. PUBLISHER: CANNABIS LAW REPORT. MORE
Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. MORE
The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. UK cannabis policy is not serving the interests of patients. MORE
CSE: BBT ) ( FSE: BBW ) ( OTC: BHHKF ) (“Benchmark”, “BBT” or the “Company”) a federally-licensed producer and distributor of medical-grade cannabis, is pleased to report that it has signed a definitive agreement with China-based Zhejiang Yatai Pharmaceutical Co., MORE
Patients who suffer from this condition also face other symptoms that are painful, inconvenient -to say the least, -and lower their quality of life. A 2016 study indicated that cannabidiol (CBD), immediately “eases anti-social and reduce anxiety-like behavior in minutes;” these findings suggest that medical marijuana is a better option over common antidepressant pharmaceuticals, which may take up to six weeks to become effective. Patient Education MORE
Fibromyalgia patients suffering from lower back pain respond favorably to medical cannabis as a treatment, according to a new study published in the journal Clinical and Experimental Rheumatology , and epublished by the National Institute of Health. For the study, researchers assessed the analgesic efficacy of both opioids and medical cannabis in 31 fibromyalgia (FM) patients with lower back pain. MORE
Dementia cannot be confirmed until a patient is deceased. Dementia is hard on the patient, and often harder on the family or caregivers. Pharmaceutical treatments for for Dementia often only target symptoms like pain or depression, but those medicines do not cure or prevent the disease. Times article examined the effectiveness of Alzheimer’s disease medications for Dementia patients earlier in the course of the disease. cannabis education Patient Education MORE
Under the terms of the Agreement, ICC will supply NUBU will a suite of full-spectrum pharmaceutical grade medical cannabis products including: Packaged and labelled medical cannabis including; oil/tincture and capsules in finished goods form. MORE
Thanks to the recent emergence of regulated medical cannabis markets, the success of this versatile plant can be followed from farm to pharma and prescriber to patient, however, the origins of cannabis as medicine cannot be as simply traced as the plant is today from seed to sale. Pharmaceutical grade cannabis is relatively new in parts of the world. Of course, patients need product and product costs money. Patients, and their treatment, therefore, are the priority. MORE
One of the obstacles that a hospice patient who chooses medicinal cannabis faces is financial burden. Currently, most hospice patients are covered through Medicare and, unfortunately, that doesn’t include this alternative treatment. MORE
To create, develop and market a variety of high content cannabinoid based pharmaceuticals, natural health products and cosmetics for international markets. About Zhejiang Yatai Pharmaceutical Co., Zhejiang Yatai Pharmaceutical Co., MORE
Separately, the company recently started recruiting patients aged 65 and over for the 16-week Phase IIB clinical trial for its CogniCann medical cannabis product for the treatment of dementia and Alzheimer’s disease. The trial at the University of Notre Dame in WA will be carried out on 50 patients to assess the effects of the treatment on the symptoms of mild dementia and Alzheimer’s and potentially improve the patient’s quality of life. Here’s the press release. MORE
Because there is limited or conflicting research about “the true nature of traumatic brain injury and how it causes chronic degenerative problems,” treatment can be a challenging process for many patients. This means that often pharmaceutical medications are experimental. One medication may work for one patient, but might be ineffective for another TBI patient. Medical marijuana can contribute to a patient’s overall health. MORE
In July, 2012, he and his wife settled in south Redding, where, at the time, the outdoor cultivation of medical cannabis was legal for qualified patients. Rubin says Willkomm claimed he’d never met an actual, honest-to-god medical marijuana patient before and seemed sympathetic to his plight. MORE
Cannabis Law Report
SEPTEMBER 24, 2019
Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy.
Cannabis Life Network
OCTOBER 8, 2019
Dissolve Strips ™ (sublingual cannabis wafers) Now Available to Aurora’s Canadian Medical Patients NYSE | TSX: ACB OTC: CTTH EDMONTON and HAMILTON, ON, Oct.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JULY 23, 2019
TSXV: LG and OTC-QB: LGGCF) (“ LGC ”) is pleased to announce that it has paid the 2 nd Tranche, as contractually agreed, in acquiring an equity interest in the Italian pharmaceutical company, Freia Farmaceutici Srl (“Freia”). This EU pharmaceutical entity is an optimal addition to LGC.
Canna Newswire
MAY 21, 2019
To create, develop and market a variety of high content cannabinoid based pharmaceuticals, natural health products and cosmetics for international markets. About Zhejiang Yatai Pharmaceutical Co., Zhejiang Yatai Pharmaceutical Co.,
Cannabis Law Report
JANUARY 13, 2020
We are proud of the positive impact this medicine has already had on thousands of patients and believe that this past year provides a compelling foundation for continued success in 2020,” said Justin Gover, GW’s Chief Executive Officer. Enquiries: GW Pharmaceuticals plc.
Cannabis Law Report
JULY 12, 2019
Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. One patient died but it was ruled to be part of the course of their disorder and not a drug effect.
|
Canna Newswire
MAY 30, 2019
CSE: BBT ) ( FSE: BBW ) ( OTC: BHHKF ) (“Benchmark”, “BBT” or the “Company”) a federally-licensed producer and distributor of medical-grade cannabis, is pleased to report that it has signed a definitive agreement with China-based Zhejiang Yatai Pharmaceutical Co.,
Cannabis Law Report
JULY 21, 2019
Under the terms of the Agreement, ICC will supply NUBU will a suite of full-spectrum pharmaceutical grade medical cannabis products including: Packaged and labelled medical cannabis including; oil/tincture and capsules in finished goods form. ICC International Cannabis Corp. CSE: WRLD.U)(FWB:
Cannabis Law Report
JULY 19, 2019
Under the terms of the Agreement, ICC will supply NUBU will a suite of full-spectrum pharmaceutical grade medical cannabis products including: Packaged and labelled medical cannabis including; oil/tincture and capsules in finished goods form.
Cannabis Law Report
JUNE 5, 2019
Press Release: Thailand Government Pharmaceutical Organization. And nervous pain Add research to various types of Parkinson’s Alzheimer’s patients. Dr. Sophon Mektana, Advisor to the Minister of Public Health And the Chairman of the Pharmaceutical Organization Committee.
CannaTech
SEPTEMBER 23, 2019
The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. UK cannabis policy is not serving the interests of patients.
|
|
Greencamp
MAY 1, 2019
Since then, countless patients found relief in cannabis, even though most of the times doctors would only recommend it when all other “mainstream” options were exhausted. However, some people don’t react well to antiemetics—most notably cancer patients going through aggressive chemo.
Canna Care Docs
JUNE 22, 2018
An Introductory Lesson on THC Basics For Medical Cannabis Patients. Cannabis, a plant that has proven to be endlessly complex is still under the microscope by researchers, patients, physicians, and society.
Cannabis Law Report
NOVEMBER 23, 2019
for the production R&D of pharmaceutical grade standardised cannabis. Here the company shares their evolution with Health Europa, exploring the production of pharmaceutical grade standardised cannabis. KANNABEIRA® is a project and a registered trademark under the company Green Donation, Ltd. KANNABEIRA and standardised cannabis.
Cannabis Law Report
MAY 29, 2019
Separately, the company recently started recruiting patients aged 65 and over for the 16-week Phase IIB clinical trial for its CogniCann medical cannabis product for the treatment of dementia and Alzheimer’s disease. The trial at the University of Notre Dame in WA will be carried out on 50 patients to assess the effects of the treatment on the symptoms of mild dementia and Alzheimer’s and potentially improve the patient’s quality of life. Here’s the press release.
Puff Puff Post
JANUARY 13, 2020
So even when patients use CBD oil with essentially no THC, doctors need to understand a lot more about the complex chemical reactions of cannabinoids and terpenes. As farmers widely grow hemp for a variety of purposes, the pharmaceutical industry is not able to control the supply of CBD oil.
CannaTech
JANUARY 16, 2019
Thanks to the recent emergence of regulated medical cannabis markets, the success of this versatile plant can be followed from farm to pharma and prescriber to patient, however, the origins of cannabis as medicine cannot be as simply traced as the plant is today from seed to sale. Pharmaceutical grade cannabis is relatively new in parts of the world. Of course, patients need product and product costs money. Patients, and their treatment, therefore, are the priority.
420 Clinic
JUNE 3, 2018
THC, and cannabinoid pharmaceuticals have been studied for several medical applications, including the treatment of nausea, pain, anorexia and weight loss, neurodegeneration and neuropathy. The post How medical cannabis can aid cancer patients appeared first on 420Clinic.
Freedom Leaf
OCTOBER 15, 2018
On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances.
Canna Newswire
JULY 11, 2019
to bring the CannatolRx Rescue Nasal Spray to Illinois patients,” said Nature’s Grace and Wellness COO Tim O’Hern. This product is a natural extension of our patient-focused mission and a product that has been missing from Illinois for far too long.”. MEDICAL CANNABIS PHARMACEUTICALS
Cannabis Law Report
SEPTEMBER 20, 2019
In May 2014, Barnaby Joyce spoke out in support of legalising cannabis medicine: a campaign fronted by a young patient named Dan Haslam. “We speculate that the tight regulation is more a means of control and restriction with the aim of keeping Australian patient numbers minimal.”
Peninsula Alternative Health
MARCH 15, 2018
One of the obstacles that a hospice patient who chooses medicinal cannabis faces is financial burden. Currently, most hospice patients are covered through Medicare and, unfortunately, that doesn’t include this alternative treatment. Written by Erin Bilenki, Patient Consultant.
Peninsula Alternative Health
MARCH 15, 2018
One of the obstacles that a hospice patient who chooses medicinal cannabis faces is financial burden. Currently, most hospice patients are covered through Medicare and, unfortunately, that doesn’t include this alternative treatment.
FloridaMarijuana.net
JULY 6, 2018
As the rate of cancer diagnoses rises worldwide, patients are finding more options with their treatments and healthcare routines. Patients can suffer from the disease itself, or from the side effects of chemotherapy and other pharmaceuticals medications. Patients report experiencing anxiety, insomnia, appetite issues, nausea, vomiting and fatigue. This epidemic affects not only patients, but their families and caregivers.
Cannabis Law Report
JULY 16, 2019
In July, 2012, he and his wife settled in south Redding, where, at the time, the outdoor cultivation of medical cannabis was legal for qualified patients. Rubin says Willkomm claimed he’d never met an actual, honest-to-god medical marijuana patient before and seemed sympathetic to his plight.
The Joint Blog
NOVEMBER 24, 2018
Fibromyalgia patients suffering from lower back pain respond favorably to medical cannabis as a treatment, according to a new study published in the journal Clinical and Experimental Rheumatology , and epublished by the National Institute of Health. For the study, researchers assessed the analgesic efficacy of both opioids and medical cannabis in 31 fibromyalgia (FM) patients with lower back pain.
FloridaMarijuana.net
AUGUST 16, 2018
Dementia cannot be confirmed until a patient is deceased. Dementia is hard on the patient, and often harder on the family or caregivers. Pharmaceutical treatments for for Dementia often only target symptoms like pain or depression, but those medicines do not cure or prevent the disease. Times article examined the effectiveness of Alzheimer’s disease medications for Dementia patients earlier in the course of the disease. cannabis education Patient Education
FloridaMarijuana.net
JULY 16, 2018
No need to take pills that could do more harm than good; or deal with painful side effects that pharmaceuticals cause. Patients that are seeking a natural and alternative medicine to the condition they are facing can register for a medical marijuana card by starting here. Furthermore, depending on the state of residency, a medical marijuana card also permits patients to cultivate their own medicine. Patient intake form. Patient Education
FloridaMarijuana.net
JULY 5, 2018
Patients often report feeling relief almost immediately. This strain is known to increase energy and a creative flow in patients; some report even feeling more focused and productive. This is not the strain for patients who suffer from insomnia which is why most patients find this strain to be most effective for daytime use. Many patients living with PTSD, anxiety and depression may find that OG Kush sufficiently helps their symptoms.
FloridaMarijuana.net
OCTOBER 19, 2018
Some patients find success with pharmaceuticals and talk-therapy. In addition to these medical interventions, Medical marijuana may also be beneficial to clinically depressed patients. Medical marijuana is another option for patients suffering from anxiety. Patient self-reporting and clinical trials are the most efficient methods of understanding how well medical cannabis can help even those with severe symptoms related to depression.
FloridaMarijuana.net
AUGUST 9, 2018
Because there is limited or conflicting research about “the true nature of traumatic brain injury and how it causes chronic degenerative problems,” treatment can be a challenging process for many patients. This means that often pharmaceutical medications are experimental. One medication may work for one patient, but might be ineffective for another TBI patient. Medical marijuana can contribute to a patient’s overall health.
FloridaMarijuana.net
OCTOBER 5, 2018
Cannabis possesses healing properties which can aid in a patient’s overall healthcare routine. In particular, terpenoids are contained in many herbal plants, and several terpenoids have been shown to be available for pharmaceutical applications. When terpenes and cannabinoids interact together, there is a heightened efficacy for medical marijuana patients. cannabis cannabis research education Health marijuana marijuana strains Patient Education Terpenes
Cannabis Law Report
FEBRUARY 26, 2019
Portugal this week rejected the idea of legalising recreational cannabis, although medicinal marijuana is now available for patients in the country. If you wish to re-publish this story please do so with following accreditation. AUTHOR: Mark Taylor. PUBLISHER: CANNABIS LAW REPORT.
FloridaMarijuana.net
JUNE 22, 2018
Patients who suffer from this condition also face other symptoms that are painful, inconvenient -to say the least, -and lower their quality of life. A 2016 study indicated that cannabidiol (CBD), immediately “eases anti-social and reduce anxiety-like behavior in minutes;” these findings suggest that medical marijuana is a better option over common antidepressant pharmaceuticals, which may take up to six weeks to become effective. Patient Education
FloridaMarijuana.net
OCTOBER 11, 2018
Cannabis possesses healing properties which can aid in a patient’s overall healthcare routine. In particular, terpenoids are contained in many herbal plants, and several terpenoids have been shown to be available for pharmaceutical applications. The trained staff at the Medical Marijuana Treatment Center will assist each patient in selecting the appropriate cannabis products. cannabis cannabis research Health marijuana strains Patient Education Terpenes
43 
Let's personalize your content